Rutkove Seward B
Harvard Medical School, and Department of Neurology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, TCC-810, Boston, MA 02215, USA.
JAMA. 2009 Oct 7;302(13):1451-8. doi: 10.1001/jama.2009.1377. Epub 2009 Sep 8.
Ms Q is a 52-year-old woman who has had progressive polyneuropathy in the setting of diabetes for the past 8 years. Ms Q's major disability is that of increasingly severe neuropathic pain and cramps that have been poorly responsive to a variety of therapies, including gabapentin and topiramate. The diagnosis of and differential diagnosis for diabetic polyneuropathy are reviewed herein. In general, treatment options for diabetic polyneuropathy remain primarily symptomatic. Improving the metabolic profile through weight loss, exercise, and if necessary, medications may help slow neuropathy progression. Many medications are effective in reducing pain, and newly developed ones, such as pregabalin and duloxetine, while specifically marketed for diabetic neuropathy, are likely to be no better and are considerably more expensive than older ones. Alpha-lipoic acid appears to be effective as well.
Q女士是一位52岁的女性,在过去8年中患有糖尿病相关的进行性多发性神经病变。Q女士的主要残疾是越来越严重的神经性疼痛和痉挛,这些症状对包括加巴喷丁和托吡酯在内的多种治疗反应不佳。本文回顾了糖尿病性多发性神经病变的诊断和鉴别诊断。一般来说,糖尿病性多发性神经病变的治疗选择主要还是对症治疗。通过减肥、运动以及必要时使用药物来改善代谢状况,可能有助于减缓神经病变的进展。许多药物在减轻疼痛方面有效,新开发的药物,如普瑞巴林和度洛西汀,虽然专门用于治疗糖尿病性神经病变,但可能并不比旧药更好,而且价格要贵得多。α-硫辛酸似乎也有效。